Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: an open-label, naturalistic study.
Maron
Eduard
E
Eller
Triin
T
Vasar
Veiko
V
Nutt
David J
DJ
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D016642:Bupropion / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D016642:Bupropion; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors